HOME >> BIOLOGY >> NEWS
Chromosome losses mean poor survival in childhood leukemia

COLUMBUS, Ohio A new international study of children with a severe form of acute lymphoblastic leukemia (ALL) shows that certain chromosome losses can signal an especially poor response to therapy, but that other chromosome abnormalities have no effect on treatment survial.

The finding should enable doctors to identify patients with severe ALL for additional or experimental therapies when such therapies become available. The study was published in the April issue of the journal Leukemia.

"Overall, we found that many chromosome abnormalities in our group of patients made no difference at all, although particular abnormalities could," says Dr. Nyla A. Heerema, a researcher with The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, and first author on the study.

"The results surprised us," she says. "We expected that additional chromosome abnormalities would mean a worse outcome."

The retrospective study involved 249 children diagnosed with ALL between 1986 and 1996 by 10 medical centers in the United States and five other countries. The children had received intensive chemotherapy and their disease had gone into complete remission.

All the children had cancers showing the Philadelphia chromosome, an alteration in the genes that indicates a poorer response to treatment. Sixty-one percent of the patients (153), showed secondary chromosome abnormalities; that is, abnormalities present in addition to the Philadelphia chromosome.

Heerema and her colleagues wanted to learn if secondary chromosome abnormalities contributed to a poor prognosis in children with ALL. They found that having most secondary chromosome abnormalities had little affect on a child's prognosis. It did, however, when they involved the loss of chromosome 7, or the part of it known as 7p, or the loss of a part of chromosome 9 known as 9p.

Among children with cancer c
'"/>

Contact: Darrell E. Ward
Ward-15@medctr.osu.edu
614-293-3737
Ohio State University
4-May-2004


Page: 1 2

Related biology news :

1. Chromosome caps predict bone marrow disease
2. Gene-rich human Chromosome 19 sequence completed
3. Chromosomes are nibbled before they fuse, researchers report
4. Chromosome assessment could predict increased risk of death from age-related disease
5. Chromosome centers defined and sequenced for model plant
6. Discovery: Chromosomes Found To End In Big Loops
7. UI Researchers Find Possible Genetic Link Between The X Chromosome And Ovarian Cancer
8. Counting X Chromosomes To Determine Sex
9. Genetic Code Of Chromosome Of Malaria Parasite Deciphered
10. Hopkins And International Team Maps First Major Cancer Gene To X Chromosome
11. UNC Scientists Succeed In Inserting Gene In Human Cells Via Artificial Chromosome

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/24/2018)... ... September 24, 2018 , ... EDETEK, the premier ... exhibiting at the Society for Clinical Data Management (SCDM) 2018 Annual Conference taking ... participating at DPHARM: Disruptive Innovations in Boston, MA on September 25-26, 2018. ...
(Date:9/24/2018)... (PRWEB) , ... September 24, 2018 , ... ... requires the hepatitis B surface antigen (HBsAg) to infect the hepatocytes. Chronic Hepatitis ... accelerated progression of cirrhosis and hepatocellular carcinoma and a high mortality rate. ...
(Date:9/24/2018)... ... September 24, 2018 , ... Energetiq Technology, a world ... announce that starting on October 1, 2018 Hamamatsu will distribute the company’s Laser-Driven ... have been working steadfastly since our acquisition to integrate with Hamamatsu and familiarize ...
Breaking Biology News(10 mins):
(Date:9/12/2018)... ... September 12, 2018 , ... NDA ... professional and former Senior Director of Regulatory Affairs and Quality Systems at WellDoc, ... Director of Regulatory Affairs and Quality Systems at WellDoc, Inc., she conducted quality ...
(Date:9/7/2018)... ANN ARBOR, Mich. (PRWEB) , ... September 06, 2018 , ... ... of Directors. Dunbar has spent his career as an executive and leader of numerous ... Biologics, a private cell therapy and biologics company acquired by Thompson Street Capital in ...
(Date:8/29/2018)... ... ... Cognition Corporation ®, a software company specializing in medical device compliance ... , Ryan Ward, Director of Engineering at Zimmer Biomet, has been announced as a ... with Zimmer Biomet for almost 15 years, Mr. Ward will focus his talk about ...
(Date:8/26/2018)... ... August 23, 2018 , ... ... innovators, engineers, and scientists from around the world, will host the 4th Annual ... an array of industries and disciplines, encompassing various research areas including medicine, agriculture, ...
Breaking Biology Technology:
Cached News: